Cargando…
RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions
Assessment of the risk of bias is an essential component of any systematic review. This is true for both nonrandomized studies and randomized trials, which are the main study designs of systematic reviews. The Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS) was developed in 2013 and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Family Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522469/ https://www.ncbi.nlm.nih.gov/pubmed/37423253 http://dx.doi.org/10.4082/kjfm.23.0034 |
_version_ | 1785110361572114432 |
---|---|
author | Seo, Hyun-Ju Kim, Soo Young Lee, Yoon Jae Park, Ji-Eun |
author_facet | Seo, Hyun-Ju Kim, Soo Young Lee, Yoon Jae Park, Ji-Eun |
author_sort | Seo, Hyun-Ju |
collection | PubMed |
description | Assessment of the risk of bias is an essential component of any systematic review. This is true for both nonrandomized studies and randomized trials, which are the main study designs of systematic reviews. The Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS) was developed in 2013 and has gained wide usage as a risk-of-bias assessment tool for nonrandomized studies. Four risk-of-bias assessment experts revised it by reviewing existing assessment tools and user surveys. The main modifications included additional domains of selection and detection bias susceptible to nonrandomized studies of interventions, a more detailed consideration of the comparability of participants, and more reliable and valid outcome measurements. A psychometric assessment of the revised RoBANS (RoBANS 2) revealed acceptable inter-rater reliability (weighted kappa, 0.25 to 0.49) and construct validity in which intervention effects of studies with an unclear or high risk of bias were overestimated. The RoBANS 2 has acceptable feasibility, fair-to-moderate reliability, and construct validity. It provides a comprehensive framework for allowing authors to assess and understand the plausible risk of bias in nonrandomized studies of interventions. |
format | Online Article Text |
id | pubmed-10522469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Korean Academy of Family Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-105224692023-09-28 RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions Seo, Hyun-Ju Kim, Soo Young Lee, Yoon Jae Park, Ji-Eun Korean J Fam Med Review Article Assessment of the risk of bias is an essential component of any systematic review. This is true for both nonrandomized studies and randomized trials, which are the main study designs of systematic reviews. The Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS) was developed in 2013 and has gained wide usage as a risk-of-bias assessment tool for nonrandomized studies. Four risk-of-bias assessment experts revised it by reviewing existing assessment tools and user surveys. The main modifications included additional domains of selection and detection bias susceptible to nonrandomized studies of interventions, a more detailed consideration of the comparability of participants, and more reliable and valid outcome measurements. A psychometric assessment of the revised RoBANS (RoBANS 2) revealed acceptable inter-rater reliability (weighted kappa, 0.25 to 0.49) and construct validity in which intervention effects of studies with an unclear or high risk of bias were overestimated. The RoBANS 2 has acceptable feasibility, fair-to-moderate reliability, and construct validity. It provides a comprehensive framework for allowing authors to assess and understand the plausible risk of bias in nonrandomized studies of interventions. Korean Academy of Family Medicine 2023-09 2023-07-07 /pmc/articles/PMC10522469/ /pubmed/37423253 http://dx.doi.org/10.4082/kjfm.23.0034 Text en Copyright © 2023 The Korean Academy of Family Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Seo, Hyun-Ju Kim, Soo Young Lee, Yoon Jae Park, Ji-Eun RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions |
title | RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions |
title_full | RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions |
title_fullStr | RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions |
title_full_unstemmed | RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions |
title_short | RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions |
title_sort | robans 2: a revised risk of bias assessment tool for nonrandomized studies of interventions |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522469/ https://www.ncbi.nlm.nih.gov/pubmed/37423253 http://dx.doi.org/10.4082/kjfm.23.0034 |
work_keys_str_mv | AT seohyunju robans2arevisedriskofbiasassessmenttoolfornonrandomizedstudiesofinterventions AT kimsooyoung robans2arevisedriskofbiasassessmenttoolfornonrandomizedstudiesofinterventions AT leeyoonjae robans2arevisedriskofbiasassessmenttoolfornonrandomizedstudiesofinterventions AT parkjieun robans2arevisedriskofbiasassessmenttoolfornonrandomizedstudiesofinterventions |